Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer (Q37885285)

24 August 2017

1 reference

title

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer (English)

1 reference

24 August 2017

1 reference

François Ghiringhelli

series ordinal

3

object named as

François Ghiringhelli

0 references

Sylvain Ladoire

series ordinal

1

object named as

Sylvain Ladoire

0 references

François Martin

series ordinal

2

object named as

François Martin

0 references

publication date

5 June 2011

1 reference

Cancer Immunology, Immunotherapy

24 August 2017

1 reference

24 August 2017

60

1 reference

24 August 2017

7

1 reference

24 August 2017

909-918

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1046-y

24 August 2017

0 references

cites work

CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Is FOXP3 a bona fide marker for human regulatory T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Increased tight junctional permeability is associated with the development of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

NF-kappaB signaling pathway, inflammation and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Inflammation and cancer: IL-6 and STAT3 complete the link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Th17 cytokines and the gut mucosal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Protumor vs antitumor functions of IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Exploring the link between microorganisms and oral cancer: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1046-Y

10.1007/S00262-011-1046-Y

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21644034